- Home
- ELVA vs XGN Comparison
ELVA vs XGN Comparison
Compare ELVA & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVA
- XGN
- Stock Information
- Founded
- ELVA 1996
- XGN 2002
- Country
- ELVA Canada
- XGN United States
- Employees
- ELVA N/A
- XGN N/A
- Industry
- ELVA
- XGN Medical Specialities
- Sector
- ELVA
- XGN Health Care
- Exchange
- ELVA Nasdaq
- XGN Nasdaq
- Market Cap
- ELVA 125.5M
- XGN 138.3M
- IPO Year
- ELVA N/A
- XGN 2019
- Fundamental
- Price
- ELVA $3.79
- XGN $7.07
- Analyst Decision
- ELVA Strong Buy
- XGN Strong Buy
- Analyst Count
- ELVA 5
- XGN 2
- Target Price
- ELVA $6.10
- XGN $7.50
- AVG Volume (30 Days)
- ELVA 77.3K
- XGN 259.6K
- Earning Date
- ELVA 08-12-2025
- XGN 08-04-2025
- Dividend Yield
- ELVA N/A
- XGN N/A
- EPS Growth
- ELVA N/A
- XGN N/A
- EPS
- ELVA N/A
- XGN N/A
- Revenue
- ELVA $48,016,000.00
- XGN $56,724,000.00
- Revenue This Year
- ELVA $55.29
- XGN $18.92
- Revenue Next Year
- ELVA $63.69
- XGN $14.78
- P/E Ratio
- ELVA N/A
- XGN N/A
- Revenue Growth
- ELVA N/A
- XGN 1.78
- 52 Week Low
- ELVA $1.67
- XGN $1.78
- 52 Week High
- ELVA $3.89
- XGN $7.95
- Technical
- Relative Strength Index (RSI)
- ELVA 67.50
- XGN 54.01
- Support Level
- ELVA $3.11
- XGN $6.57
- Resistance Level
- ELVA $3.89
- XGN $7.15
- Average True Range (ATR)
- ELVA 0.19
- XGN 0.33
- MACD
- ELVA 0.04
- XGN -0.04
- Stochastic Oscillator
- ELVA 94.23
- XGN 61.73
About ELVA Electrovaya Inc.
Electrovaya Inc designs develop and manufacture proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. It is a technology-focused company with extensive IP. The company generates revenue from the sale of batteries and battery systems. Business operations are segmented based on large format batteries and others. This technology offers enhanced safety and battery longevity. Geographically it earns key revenue from the United States.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.